Venrock Healthcare Capital Partners III, L.P. Insider Trading Activity
Venrock Healthcare Capital Partners III, L.P., an institutional filer, recorded 5 transactions over the last 12 months across 1 company totaling $3.7M.
Activity concentrated in KALV with 5 filings. The largest single transaction was a sale of KALV for $3.0M on Mar 25, 2026.
Performance Scorecard
Forward stock performance after each transaction by Venrock Healthcare Capital Partners III, L.P.. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -7.5% | 0% | 5 |
| 90 days | — | — | — | — |
| 120 days | — | — | — | — |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKALV · KalVista Pharmaceuticals, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Venrock Healthcare Capital Partners III, L.P. bought and sold KALV.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 26, 2026 | KALV | Sell | 21,386 | $17.76 | $380K | −0.4% | 10%+ Owner | |
Mar 26, 2026 | KALV | Sell | 15,417 | $18.82 | $290K | −0.3% | 10%+ Owner | |
Mar 26, 2026 | KALV | Sell | 3,183 | $19.12 | $61K | −0.1% | 10%+ Owner | |
Mar 25, 2026 | KALV | Sell | 174,485 | $16.95 | $3.0M | −3.3% | 10%+ Owner | |
Mar 25, 2026 | KALV | Sell | 160 | $17.53 | $3K | −0.0% | 10%+ Owner |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | 5 | $3.7M |
Other insiders at KalVista Pharmaceuticals, Inc.
5 other tracked filers at KALV.